Modification of the crystal habit of celecoxib for improved processability

被引:33
|
作者
Banga, Sheere
Chawla, Garima
Varandani, Deepak
Mehta, B. R.
Bansal, Arvind K.
机构
[1] NIPER, Dept Pharmaceut Technol Formulat, SAS Nagar 160062, Punjab, India
[2] Indian Inst Technol, Dept Phys, New Delhi 110016, India
关键词
D O I
10.1211/jpp.59.1.0005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Crystallization is often used in the pharmaceutical industry for purification and isolation of drugs, and also as a means of generating polymorphs or isomorphs. The aim of this study was to investigate the role of extrinsic crystallization parameters on the crystallized product, with special emphasis on improving the mechanical properties of acicular celecoxib. Celecoxib isomorphs were prepared using different techniques (solvent crystallization and vapour diffusion) and crystallization conditions (solvents, stirring, degree of supersaturation, crystallization temperature and seeding). Powder X-ray diffractometry, spectroscopic and thermal methods were used to investigate physical characteristics of crystals. Growth kinetics and aggregation dynamics of crystallization in polar and non-polar solvents were simulated using a dynamic light scattering method. The quick appearance of broad peaks over the range of 10-8000 nm in chloroform during crystallization simulation studies indicated faster aggregation in non-polar solvents. Aspect ratio, flow, compressibility and surface area of recrystallized products were also determined. Surface topography was determined by atomic force microscopy and the lath-shaped crystals (aspect ratio of 2-4) exhibited a roughness index of 1.79 in comparison with 2.92 for needles. Overall, the lath-shaped isomorphs exhibited improved flow and better compressibility.
引用
收藏
页码:29 / 39
页数:11
相关论文
共 50 条
  • [1] Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib
    Modi, Sameer R.
    Dantuluri, Ajar K. R.
    Puri, Vibha
    Pawar, Yogesh B.
    Nandekar, Prajwal
    Sangamwar, Abhay T.
    Perumalla, Sathyanarayana R.
    Sun, Changquan Calvin
    Bansal, Arvind K.
    CRYSTAL GROWTH & DESIGN, 2013, 13 (07) : 2824 - 2832
  • [2] Downstream Processability of Crystal Habit-Modified Active Pharmaceutical Ingredient
    Pudasaini, Nawin
    Upadhyay, Pratik P.
    Parker, Christian R.
    Hagen, Stefan U.
    Bond, Andrew D.
    Rantanen, Jukka
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2017, 21 (04) : 571 - 577
  • [3] POLYMER MEDIATED CRYSTAL HABIT MODIFICATION
    CARRIER, AM
    STANDISH, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 35 - COLL
  • [4] Influence of solvents on the crystal habit and properties of rofecoxib and celecoxib: No evidence of polymorphism
    Raval, M. K.
    Babu, P. R. Sathesh
    Thimmasetty, J.
    Parikh, R. K.
    Sheth, N. R.
    Subrahmanyam, C. V. S.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2010, 1 (02) : 40 - 50
  • [5] SUCROSE CRYSTAL HABIT MODIFICATION IN PRESENCE OF IMPURITIES
    MANTOVANI, G
    ACCORSI, CA
    VACCARI, G
    ZEITSCHRIFT FUR DIE ZUCKERINDUSTRIE, 1977, 27 (05): : 286 - 290
  • [6] MODIFICATION OF CRYSTAL HABIT OF INORGANIC SALTS WITH DYES
    WHETSTONE, J
    NATURE, 1951, 168 (4276) : 663 - 664
  • [7] Effect of Crystal Habit on Intrinsic Dissolution Behavior of Celecoxib Due to Differential Wettability
    Modi, Sameer R.
    Dantuluri, Ajay K. R.
    Perumalla, Sathyanarayana R.
    Sun, Changquan Calvin
    Bansal, Arvind K.
    CRYSTAL GROWTH & DESIGN, 2014, 14 (10) : 5283 - 5292
  • [8] CRYSTAL HABIT MODIFICATION BY WATER-SOLUBLE POLYMERS
    SARIG, S
    JOURNAL OF CRYSTAL GROWTH, 1974, 24 (OCT) : 338 - 341
  • [9] CRYSTAL HABIT MODIFICATION OF AGCL BY IMPURITIES DETERMINING SOLVATION
    CLAES, FH
    LIBEER, J
    VANASSCHE, W
    JOURNAL OF PHOTOGRAPHIC SCIENCE, 1973, 21 (01): : 39 - 50
  • [10] CRYSTAL HABIT MODIFICATION OF A TABLET LUBRICANT, ADIPIC ACID
    FAIRBROTHER, JE
    GRANT, DJW
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 : P19 - P19